From Ojer Pharma we focused all our efforts in the research and development of new dermatological products, while we seek to optimize our resources through an adequate R&D management based on the standards UNE 166002 (I+D+I management). Thus, we are able to:
The innovation management faces the pharmaceutical development as a whole, considering all aspects
from the technological surveillance to the authorization of the product on the market. Innovation
management consists of several parts shown in the graphic below:
Ojer Pharma collaborates closely with two of the most nationally prestigious universities in the biomedical sector, as well as with their research centers and developing structures: Universidad de Navarra and University of Barcelona